A. D. R. Huitema

Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial

Markus Joerger, A. D. R. Huitema, S. Krähenbühl et al. · British Journal of Cancer · 2010 · 85 citations · Full text

Medicine, Oncology, Pharmacology +15

Effects of cytochrome P450 3A (CYP3A) and the drug transporters P‐glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir

RAB van Waterschoot, Rob ter Heine, Els Wagenaar et al. · British Journal of Pharmacology · 2010 · 70 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Validation of techniques for the prediction of carboplatin exposure: Application of Bayesian methods

A. D. R. Huitema · Clinical Pharmacology & Therapeutics · 2000 · 52 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetic-Pharmacodynamic Analysis of Trastuzumab-Associated Cardiotoxicity

J. G. Coen van Hasselt, AH Boekhout, J. H. Beijnen et al. · Clinical Pharmacology & Therapeutics · 2011 · 36 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer

Merel van Nuland, Stefanie L. Groenland, Andries M. Bergman et al. · Prostate Cancer and Prostatic Diseases · 2019 · 28 citations · Full text

Medicine, Oncology, Pharmacology +16